Found: 10
Select item for more details and to access through your institution.
Antibiotics and coronary heart disease.
- Published in:
- 2004
- By:
- Publication type:
- commentary
A prospective evaluation of the angiotensin-converting enzyme D/I polymorphism and left ventricular remodeling in the ‘Healing and Early Afterload Reducing Therapy’ Study.
- Published in:
- Clinical Genetics, 2002, v. 61, n. 1, p. 21, doi. 10.1034/j.1399-0004.2002.610104.x
- By:
- Publication type:
- Article
Corticosteroid suppression of lipoxin A4 and leukotriene B4 from alveolar macrophages in severe asthma.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Left ventricular systolic and diastolic function, remodelling, and clinical outcomes among patients with diabetes following myocardial infarction and the influence of direct renin inhibition with aliskiren.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity (CHARM) programme.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
- Published in:
- 2009
- By:
- Publication type:
- journal article
Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article